Table 27 Anti-inflammatory screening results
From: Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review
Comp. | Time | |||
|---|---|---|---|---|
1Â h | 2Â h | 3Â h | 4Â h | |
23a | 0.78 ± 0.022 | 1.45 ± 0.057 | 0.5 ± 0.027 | 0.08 ± 0.003 |
23b | 0.55 ± 0.0389 | 1.583 ± 0.045 | 0.616 ± 0.0315 | 0.3 ± 0.023 |
23c | 0.64 ± 0.011 | 1.4 ± 0.038 | 0.31 ± 0.024 | 0.31 ± 0.024 |
23d | 0.82 ± 0.030 | 1.76 ± 0.07 | 0.58 ± 0.03 | 0.1 ± 0.002 |
Control | 0.90 ± 0.04 | 1.60 ± 0.018 | 2.38 ± 0.02 | 3.25 ± 0.03 |
Diclofenac sodium | 0.95 ± 0.03 | 1.72 ± 0.03 | 0.60 ± 0.03 | 0.60 ± 0.02 |